Anti-STK3/MST-2 抗体 [EP1466Y]
Anti-STK3/MST-2 antibody [EP1466Y]
- RabMAb
- Recombinant
- KO Validated
- 詳細を見る
Be the first to review this product! Submit a review
|
(49 Publications)
Rabbit Recombinant Monoclonal STK3/MST-2 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human, Rat, Mouse samples. Cited in 49 publications.
別名を表示する
KRS1, MST2, STK3, Serine/threonine-protein kinase 3, Mammalian STE20-like protein kinase 2, STE20-like kinase MST2, Serine/threonine-protein kinase Krs-1, MST-2
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-STK3/MST-2 antibody [EP1466Y] (AB52641)
Immunohistochemical staining of paraffin embedded human breast carcinoma with purified ab52641 at a working dilution of 1/50. The secondary antibody used is ab97051, a goat anti-rabbit IgG (H&L) at a dilution of 1/500. The sample is counter-stained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer, pH 9.0. PBS was used instead of the primary antibody as the negative control, and is shown in the inset.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-STK3/MST-2 antibody [EP1466Y] (AB52641)
ab52641 staining STK3/MST-2 in wild-type HAP1 cells (top panel) and STK3/MST-2 knockout HAP1 cells (bottom panel). The cells were fixed with 4% formaldehyde (10min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab52641 at 5μg/ml concentration and ab195889 at 1/250 dilution (shown in pseudo colour red) overnight at +4°C, followed by a further incubation at room temperature for 1h with a goat secondary antibody to Rabbit IgG (Alexa Fluor® 488) (ab150081) at 2 μg/ml (shown in green). Nuclear DNA was labelled in blue with DAPI.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-STK3/MST-2 antibody [EP1466Y] (AB52641)
Confocal image showing cytoplasmic staining of STK3/MST-2 in NIH/3T3 (mouse embryonic fibroblast) cells using ab52641 . The cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. The cells were then incubated with ab52641 at 1/70 dilution and counterstained with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) at 1/100 dilution (red). Goat anti Rabbit IgG (Alexa Fluor® 488) (ab150077) was used as the secondary antibody at 1/1000 dilution (green). Nuclei counterstained with DAPI (blue).
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-STK3/MST-2 antibody [EP1466Y] (AB52641)
NIH/3T3 (Mouse embryonic fibroblast) cells were fixed with4% paraformaldehyde and permeabilised with 90% methanol. The primary antibody (ab52641) was used at a 1/70 dilution (1 μg) (red). A Goat anti rabbit IgG (Alexa Fluorr® 488, ab150077) was used as the secondary antibody at a 1/2000 dilution. A Rabbit monoclonal IgG (ab172730) (black) was used as an isotype control.Cells without incubation with primary antibody and secondary antibody were used as an unlabelled control (blue).
- WB
Lab
Western blot - Anti-STK3/MST-2 antibody [EP1466Y] (AB52641)
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-STK3/MST-2 antibody [EP1466Y] (ab52641) at 1/50000 dilution
Lane 1:
HEK293 whole cell lysate at 10 µg
Lane 2:
HeLa whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 56 kDa
Observed band size: 56 kDa
false
- WB
Lab
Western blot - Anti-STK3/MST-2 antibody [EP1466Y] (AB52641)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : STK3/MST-2 knockout HAP1 cell lysate (20 μg)
Lane 3 : NIH/3T3 cell lysate (20 μg)
Lane 4 : 293T cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab52641 observed at 56 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab52641 was shown to specifically react with STK3/MST-2 when STK3/MST-2 knockout samples were used. Wild-type and STK3/MST-2 knockout samples were subjected to SDS-PAGE. ab52641 and ab8245 (loading control to GAPDH) were diluted 1/10 000 and 1/2000 and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-STK3/MST-2 antibody [EP1466Y] (ab52641)
Predicted band size: 56 kDa
false
- WB
Unknown
Western blot - Anti-STK3/MST-2 antibody [EP1466Y] (AB52641)
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-STK3/MST-2 antibody [EP1466Y] (ab52641) at 1/50000 dilution
Lane 1:
C6 whole cell lysate at 10 µg
Lane 2:
NIH/3T3 whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 56 kDa
Observed band size: 56 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-STK3/MST-2 antibody [EP1466Y] (AB52641)
ab52641 (purified) at 1/50 immunoprecipitating STK3/MST-2 in 10 μg C6 cell lysate (Lanes 1 and 2, observed at 56 kDa). Lane 3 - Rabbit monoclonal IgG (ab172730). For western blotting, HRP Veriblot for IP (ab131366) was used for detection (1/10 000). Blocking buffer and concentration : 5% NFDM/TBST Dilution buffer and concentration : 5% NFDM/TBST
All lanes:
Immunoprecipitation - Anti-STK3/MST-2 antibody [EP1466Y] (ab52641)
Predicted band size: 56 kDa
false
関連する標識済み抗体及び組成の異なる製品 (10)
-
578 PE
PE Anti-STK3 / MST-2 antibody [EP1466Y]
-
660 APC
APC Anti-STK3 / MST-2 antibody [EP1466Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-STK3 / MST-2 antibody [EP1466Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-STK3 / MST-2 antibody [EP1466Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-STK3 / MST-2 antibody [EP1466Y]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-STK3 / MST-2 antibody [EP1466Y]
-
Anti-STK3/MST-2 antibody [EP1466Y] - BSA and Azide free
-
HRP Anti-STK3 / MST-2 antibody [EP1466Y]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-STK3 / MST-2 antibody [EP1466Y]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-STK3/MST-2 antibody [EP1466Y]
Reactivity data
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
STK3/MST-2 is a core component of the Hippo signaling pathway which controls organ size by regulating cell proliferation and apoptosis. MST-2 often interacts with other proteins and participates in functional complexes notably with MOB1 and LATS1/2. These interactions are essential for transmitting growth inhibitory signals. Through its kinase activity MST-2 phosphorylates and activates these molecules initiating a cascade that ultimately influences gene expression impacting cell cycle and cell death processes.
Pathways
MST-2 plays a pivotal role not only in the Hippo pathway but also in the MAPK signaling network. In the Hippo pathway MST-2 phosphorylates components like LATS1/2 subsequently affecting the translocation and activity of YAP/TAZ transcription factors which control cell proliferation and survival. In the MAPK pathway MST-2 can interact with other kinases such as ASK1 to influence stress response signaling. These interactions demonstrate how MST-2 integrates signals between pathways to mediate critical decisions in cell life and death.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (49)
Recent publications for all applications. Explore the full list and refine your search
Neoplasia (New York, N.Y.) 60:101102 PubMed39674114
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biomedical science 31:100 PubMed39497128
2024
Applications
Unspecified application
Species
Unspecified reactive species
Breast cancer research : BCR 26:105 PubMed38937788
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 300:107311 PubMed38657866
2024
Applications
Unspecified application
Species
Unspecified reactive species
mBio 15:e0342923 PubMed38624208
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cellular oncology (Dordrecht, Netherlands) 47:1295-1314 PubMed38436783
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 42:113535 PubMed38060450
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 51:10568-10589 PubMed37739411
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of general medicine 16:3115-3124 PubMed37496599
2023
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 42:e112900 PubMed37350545
2023
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com